Related Experiment Video
Updated: Aug 10, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Inhibition of cartilage destruction by double gene transfer of IL-1Ra and IL-10 involves the activin pathway
E Neumann1, M Judex, F Kullmann
1Department of Internal Medicine I, University of Regensburg, Germany.
Abstract:
The objective of the study was to determine the effects and the molecular background of interleukin-1 receptor antagonist (IL-1Ra) and vIL-10 double gene transfer into human synovial fibroblasts from patients with rheumatoid arthritis (RA) using the SCID mouse model for cartilage erosion in RA. RA synovial fibroblasts were transduced with retro- or adenoviruses encoding IL-1Ra and/or viral IL-10 (vIL-10). SCID mice were engrafted subcutaneously with IL-1Ra and vIL-10 transduced human rheumatoid synovial fibroblasts and normal cartilage. In parallel, gene expression analysis before and after gene transfer using RNA arbitrarily primed PCR in combination with cDNA array was performed. vIL-10 and IL-1Ra double gene transfer resulted in inhibition of cartilage invasion and degradation by RA synovial fibroblasts when compared with control transduced and non-transduced implants. Expression of key genes that were altered after double gene transfer were related to the activin pathway. The results demonstrate not only that virus-based gene transfer using a combination of two joint-protective genes is a feasible approach to inhibit cartilage degradation by activated RA synovial fibroblasts, but also that the underlying molecular effects include modulation of the activin pathway.
Insights
Double gene transfer of interleukin-1 receptor antagonist (IL-1Ra) and viral IL-10 (vIL-10) effectively inhibited rheumatoid arthritis (RA) fibroblast cartilage degradation. This approach modulates the activin pathway, offering a potential therapy for RA joint erosion.
Area of Science:
- Immunology
- Gene Therapy
- Rheumatology
Background:
- Rheumatoid arthritis (RA) involves synovial fibroblast activation leading to cartilage degradation.
- Interleukin-1 receptor antagonist (IL-1Ra) and viral IL-10 (vIL-10) are key anti-inflammatory and cartilage-protective cytokines.
- Developing effective gene therapies for RA remains a critical challenge.
Purpose of the Study:
- To investigate the efficacy of combined IL-1Ra and vIL-10 gene transfer into RA synovial fibroblasts.
- To elucidate the molecular mechanisms underlying the effects of this double gene transfer in a SCID mouse model.
- To assess the impact on cartilage erosion in RA.
Main Methods:
- Retroviral and adenoviral vectors were used for gene transfer of IL-1Ra and vIL-10 into human RA synovial fibroblasts.
- SCID mice were engrafted with transduced fibroblasts and normal cartilage to model RA cartilage erosion.
- Gene expression analysis (RNA arbitrarily primed PCR and cDNA array) was performed before and after gene transfer.
Main Results:
- Combined IL-1Ra and vIL-10 gene transfer significantly inhibited cartilage invasion and degradation by RA synovial fibroblasts.
- Compared to controls, implants with double gene transfer showed reduced cartilage damage.
- Gene expression analysis revealed that the activin pathway was modulated by the double gene transfer.
Conclusions:
- Virus-based gene transfer of IL-1Ra and vIL-10 is a feasible strategy to inhibit RA fibroblast-mediated cartilage degradation.
- The therapeutic effects involve the modulation of the activin pathway.
- This combined gene therapy approach holds promise for treating RA joint destruction.
Related Concept Videos
Hedgehog Signaling Pathway
Growth of Cartilage and Bone Tissue
TGF - β Signaling Pathway
Bone Remodeling and Repair
Bone Formation by Endochondral Ossification
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

